Wendeler M, Beilhartz G, Beutler J, Gotte M, Le Grice S
HIV Ther. 2024; 3(1):39-53.
PMID: 38961883
PMC: 11221599.
DOI: 10.2217/17584310.3.1.39.
DeStefano J, Iseni F, Tarbouriech N
Viruses. 2022; 14(2).
PMID: 35215961
PMC: 8880465.
DOI: 10.3390/v14020369.
Ilina T, Brosenitsch T, Sluis-Cremer N, Ishima R
Enzymes. 2021; 50:227-247.
PMID: 34861939
PMC: 8994160.
DOI: 10.1016/bs.enz.2021.07.007.
Raghunathan G, Marx A
Sci Rep. 2019; 9(1):590.
PMID: 30679705
PMC: 6345897.
DOI: 10.1038/s41598-018-37233-y.
Figiel M, Krepl M, Park S, Poznanski J, Skowronek K, Golab A
J Biol Chem. 2017; 293(1):191-202.
PMID: 29122886
PMC: 5766924.
DOI: 10.1074/jbc.M117.798256.
Coordination between the polymerase and RNase H activity of HIV-1 reverse transcriptase.
Figiel M, Krepl M, Poznanski J, Golab A, Sponer J, Nowotny M
Nucleic Acids Res. 2017; 45(6):3341-3352.
PMID: 28108662
PMC: 5389522.
DOI: 10.1093/nar/gkx004.
HIV-1 Reverse Transcriptase Polymerase and RNase H (Ribonuclease H) Active Sites Work Simultaneously and Independently.
Li A, Li J, Johnson K
J Biol Chem. 2016; 291(51):26566-26585.
PMID: 27777303
PMC: 5159515.
DOI: 10.1074/jbc.M116.753160.
Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6.
Corona A, Meleddu R, Esposito F, Distinto S, Bianco G, Masaoka T
PLoS One. 2016; 11(1):e0147225.
PMID: 26800261
PMC: 4723341.
DOI: 10.1371/journal.pone.0147225.
Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociation.
Beilhartz G, Ngure M, Johns B, DeAnda F, Gerondelis P, Gotte M
J Biol Chem. 2014; 289(23):16270-7.
PMID: 24719329
PMC: 4047396.
DOI: 10.1074/jbc.M114.569707.
Molecular dynamics study of HIV-1 RT-DNA-nevirapine complexes explains NNRTI inhibition and resistance by connection mutations.
Vijayan R, Arnold E, Das K
Proteins. 2013; 82(5):815-29.
PMID: 24174331
PMC: 4502926.
DOI: 10.1002/prot.24460.
Role of the K101E substitution in HIV-1 reverse transcriptase in resistance to rilpivirine and other nonnucleoside reverse transcriptase inhibitors.
Xu H, Colby-Germinario S, Huang W, Oliveira M, Han Y, Quan Y
Antimicrob Agents Chemother. 2013; 57(11):5649-57.
PMID: 24002090
PMC: 3811317.
DOI: 10.1128/AAC.01536-13.
Complexes of HIV-1 RT, NNRTI and RNA/DNA hybrid reveal a structure compatible with RNA degradation.
Lapkouski M, Tian L, Miller J, Le Grice S, Yang W
Nat Struct Mol Biol. 2013; 20(2):230-236.
PMID: 23314251
PMC: 3973182.
DOI: 10.1038/nsmb.2485.
Mutagenesis of human immunodeficiency virus reverse transcriptase p51 subunit defines residues contributing to vinylogous urea inhibition of ribonuclease H activity.
Chung S, Miller J, Johnson B, Hughes S, Le Grice S
J Biol Chem. 2011; 287(6):4066-75.
PMID: 22105069
PMC: 3281700.
DOI: 10.1074/jbc.M111.314781.
HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors.
Beilhartz G, Gotte M
Viruses. 2011; 2(4):900-926.
PMID: 21994660
PMC: 3185654.
DOI: 10.3390/v2040900.
Impact of primer-induced conformational dynamics of HIV-1 reverse transcriptase on polymerase translocation and inhibition.
Auger A, Beilhartz G, Zhu S, Cauchon E, Falgueyret J, Grobler J
J Biol Chem. 2011; 286(34):29575-83.
PMID: 21737446
PMC: 3190998.
DOI: 10.1074/jbc.M111.268235.
Synthesis, activity, and structural analysis of novel α-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H.
Chung S, Himmel D, Jiang J, Wojtak K, Bauman J, Rausch J
J Med Chem. 2011; 54(13):4462-73.
PMID: 21568335
PMC: 3133734.
DOI: 10.1021/jm2000757.
Requirements for efficient minus strand strong-stop DNA transfer in human immunodeficiency virus 1.
Piekna-Przybylska D, Bambara R
RNA Biol. 2011; 8(2):230-6.
PMID: 21444998
PMC: 3230551.
DOI: 10.4161/rna.8.2.14802.
Selective enhancement of nucleases by polyvalent DNA-functionalized gold nanoparticles.
Prigodich A, Alhasan A, Mirkin C
J Am Chem Soc. 2011; 133(7):2120-3.
PMID: 21268581
PMC: 3081637.
DOI: 10.1021/ja110833r.
Comparative biochemical analysis of recombinant reverse transcriptase enzymes of HIV-1 subtype B and subtype C.
Xu H, Quan Y, Asahchop E, Oliveira M, Moisi D, Wainberg M
Retrovirology. 2010; 7:80.
PMID: 20929562
PMC: 2959035.
DOI: 10.1186/1742-4690-7-80.
The M230L nonnucleoside reverse transcriptase inhibitor resistance mutation in HIV-1 reverse transcriptase impairs enzymatic function and viral replicative capacity.
Xu H, Quan Y, Schader S, Oliveira M, Bar-Magen T, Wainberg M
Antimicrob Agents Chemother. 2010; 54(6):2401-8.
PMID: 20308384
PMC: 2876396.
DOI: 10.1128/AAC.01795-09.